These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2513175)

  • 1. An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugs.
    Rordorf-Adam C; Lazdins J; Woods-Cook K; Alteri E; Henn R; Geiger T; Feige U; Towbin H; Erard F
    Drugs Exp Clin Res; 1989; 15(8):355-62. PubMed ID: 2513175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes.
    Chang DM; Baptiste P; Schur PH
    J Rheumatol; 1990 Sep; 17(9):1148-57. PubMed ID: 1981242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
    McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line.
    Sugimoto M; Inoue T; Yamashita M; Takeshita K; Nakaike S
    Drugs Exp Clin Res; 2002; 28(5):197-205. PubMed ID: 12635495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
    Jang CH; Choi JH; Byun MS; Jue DM
    Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro.
    Danis VA; Franic GM; Brooks PM
    Drugs Exp Clin Res; 1991; 17(12):549-54. PubMed ID: 1841047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
    J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
    Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
    J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
    Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
    J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG synthesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro.
    Martinez F; Coleman JW
    Clin Exp Immunol; 1989 May; 76(2):252-7. PubMed ID: 2788047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases.
    Déage V; Burger D; Dayer JM
    Eur Cytokine Netw; 1998 Dec; 9(4):663-8. PubMed ID: 9889411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
    Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
    J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone and cyclosporin A modulation of human retinal pigment epithelial cell monocyte chemotactic protein-1 and interleukin-8.
    Kurtz RM; Elner VM; Bian ZM; Strieter RM; Kunkel SL; Elner SG
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):436-45. PubMed ID: 9040477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of TNF alpha, IL-1 beta and MIP-1 alpha in LPS-induced organ injury].
    Qiu H; Pan J; Zhao Y
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):254-7. PubMed ID: 8758268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
    Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
    Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
    Berkman N; John M; Roesems G; Jose PJ; Barnes PJ; Chung KF
    J Immunol; 1995 Nov; 155(9):4412-8. PubMed ID: 7594602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.